Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04726046Phase 1Completed
Phase 1, randomised, open-label trial of cefotetan in cholecystitis (2 arms), sponsored by Jeonbuk National University Hospital. Primary endpoint: Surgical complication at 30 days. Started Apr 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04726046.